| Net Cash Provided by (Used in) Operating Activities |
$136,561 |
USD |
43% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$500,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$18,610 |
USD |
-117% |
Q1 2025 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
1 |
USD/shares |
|
Q2 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$348,472 |
USD |
145% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,053,154 |
USD |
4.6% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$941,705 |
USD |
7.3% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$111,449 |
USD |
-14% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$378,820 |
USD |
|
Q4 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |